Dr. Danzhou Yang is a Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University and the Martha and Fred Borch Chair in Cancer Therapeutics, and a Member of Purdue Cancer Center and Purdue Institute of Drug Discovery. Before she moved to Purdue University, she was a Professor of Medicinal Chemistry at the University of Arizona and a comprehensive member of Arizona Cancer Center and BIO5 Institute. She received her B.S. degree from the University of Science and Technology of China, Ph.D. degree from the University of Illinois at Urbana-Champaign, and post-doctoral training in the College of Pharmacy at the University of Kentucky. Her research program focuses on cancer-specific DNA-associated molecular targets, such as MYC, BCL-2, and VEGF, and structure-based rational design of new anticancer drugs targeting DNA and DNA-associated proteins.
Gibson Oncology,LLC is composed of proven academic researchers and bio tech entrepreneurs who are excited to be developing effective and safer novel oncology drugs to treat resistant cancers with a focus on children.